Danaher Corp (DHR)

162.25 -0.23  -0.14% NYSE Jan 24, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
04/17/2020 09:00 EDT Misc Danaher Corp First Quarter Earnings Conference Call in 2020
04/17/2020 Earnings Danaher Corp First Quarter Earnings in 2020 Release
01/30/2020 08:00 EST Misc Danaher Corp Fourth Quarter Earnings Conference Call for 2019
01/30/2020 Earnings Danaher Corp Fourth Quarter Earnings in 2019 Release
12/26/2019 Dividends Amount: 0.17, Declared Date: Dec 10 2019, Pay Date: Jan 31 2020
10/24/2019 08:00 EDT Misc Danaher Corp Third Quarter Earnings Conference Call for 2019
10/24/2019 Earnings Danaher Corp Third Quarter Earnings in 2019 Release
09/26/2019 Dividends Amount: 0.17, Declared Date: Sep 10 2019, Pay Date: Oct 25 2019
07/18/2019 08:00 EDT Misc Danaher Corp Second Quarter Earnings Conference Call in 2019
07/18/2019 Earnings Danaher Corp Second Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.danaher.com
  • Investor Relations URL: http://investors.danaher.com/
  • HQ State/Province: District of Columbia
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Jan. 30, 2020
  • Last Earnings Release: Oct. 24, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 26, 2019
  • Description: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), and environmental and applied solutions (22%). In late 2019, Danaher separated from its dental business (14% of 2018 sales) through an initial public offering process and also made plans to acquire GE's Biopharma business, which will add to its life sciences segment.

Top Fund Holders

Symbol Name Weighting
PHO Invesco Water Resources ETF 8.39%
IHI iShares US Medical Devices ETF 7.95%
PRILX Parnassus Core Equity Institutional 3.59%
PACLX T. Rowe Price Capital Appreciation Adv 3.13%
PAVLX T. Rowe Price Value Adv 2.74%
XLV Health Care Select Sector SPDR® ETF 2.68%
IYH iShares US Healthcare ETF 2.48%
VDIGX Vanguard Dividend Growth Inv 2.22%
VHT Vanguard Health Care ETF 2.14%
EBVLX MFS Value 529B 1.77%
MTUM iShares Edge MSCI USA Momentum Fctr ETF 1.53%
RRBGX T. Rowe Price Blue Chip Growth R 1.27%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.